ArticleCancers2021

HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer.

Tony C Y Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.